Prednisone 20 mg Twice Daily Taper Strategy
For a patient on prednisone 40 mg daily (20 mg twice daily), taper more rapidly while in the supraphysiologic range down to approximately 4-6 mg daily, then slow the taper dramatically once approaching physiologic dosing, with decrements as small as 1 mg every 2-6 weeks guided by clinical response. 1
Initial Rapid Taper Phase (40 mg → 5-6 mg daily)
Starting from 40 mg daily, you can taper relatively quickly since you're well above physiologic replacement doses:
- Decrease by 5-10 mg every 1-2 weeks until reaching approximately 10 mg daily
- Then decrease by 2.5-5 mg every 1-2 weeks until reaching 5-6 mg daily
- This rapid taper in the supraphysiologic range minimizes cumulative steroid exposure and adverse effects 1
Critical timing consideration: Consolidate to a single morning dose (before 9 am) once you reach approximately 10-15 mg daily to minimize HPA axis suppression 2. The twice-daily dosing at higher doses helps maintain therapeutic effect, but single morning dosing aligns with physiologic cortisol rhythms.
Slow Taper Phase (5-6 mg → discontinuation)
Once at physiologic dosing (4-6 mg prednisone equivalent), the taper must become much slower because you're now dealing with potential HPA axis suppression:
- Decrease by 1 mg every 2-4 weeks (or even every 4-6 weeks if withdrawal symptoms occur)
- Monitor closely for glucocorticoid withdrawal syndrome: fatigue, myalgias, arthralgias, malaise 1
- If severe withdrawal symptoms develop, temporarily increase back to the last tolerated dose and extend the taper duration 1
HPA Axis Recovery Assessment
Do not routinely test for adrenal insufficiency while still on supraphysiologic doses 1. Testing becomes relevant only when:
- At physiologic doses (≤5-6 mg daily) and planning to discontinue
- Two options at this point 1:
- Continue gradual taper with clinical monitoring for adrenal insufficiency symptoms
- Check morning serum cortisol (drawn at 8 am, at least 24 hours after last prednisone dose)
Morning cortisol interpretation 1:
- >300 nmol/L (10 μg/dL): HPA axis recovered, safe to stop glucocorticoids
- 150-300 nmol/L (5-10 μg/dL): Continue physiologic dose, recheck in weeks to months
- <150 nmol/L (5 μg/dL): Continue physiologic dose, recheck in several months
Critical Caveats
Duration matters more than dose: If this patient has been on prednisone <3-4 weeks, you can stop abruptly without tapering regardless of dose 1. However, if >3-4 weeks, tapering is essential.
Only taper if the underlying disease is controlled 1. Do not attempt to taper if glucocorticoids are still needed for disease management—this leads to disease flare and unnecessary suffering.
Glucocorticoid withdrawal syndrome is distinct from adrenal insufficiency and presents with similar symptoms (fatigue, myalgias, malaise) but occurs despite adequate cortisol levels. This is common during tapering and may require slowing the taper or temporarily increasing the dose 1.
Stress dosing: While tapering or within 12 months of stopping, patients remain at risk for adrenal crisis during physiologic stress (surgery, severe illness). They need stress-dose coverage during these periods 1, 3.
Practical Example Taper Schedule
For a patient on 40 mg daily with controlled underlying disease:
- Weeks 1-2: 30 mg daily (single morning dose)
- Weeks 3-4: 20 mg daily
- Weeks 5-6: 15 mg daily
- Weeks 7-8: 10 mg daily
- Weeks 9-10: 7.5 mg daily
- Weeks 11-12: 6 mg daily
- Weeks 13-16: 5 mg daily
- Then decrease by 1 mg every 2-4 weeks: 4 mg → 3 mg → 2 mg → 1 mg → stop
- Consider morning cortisol when at 5 mg or below to guide final discontinuation
This approach balances minimizing steroid exposure (rapid taper at high doses) with preventing adrenal crisis (slow taper at physiologic doses) 1, 4.